PhD Thesis in Human Immunology (dendritic cell biology)
Join the FlavImmunity project, which is a collaborative effort of four research groups at LMU Munich, Institut Pasteur and Institut Cochin (Paris) funded by the German Research Foundation (DFG) and the French National Research Agency (ANR).
The overall aim of the joint project is to understand the mechanisms of yellow fever vaccine 17D efficacy, which will allow designing new approaches towards a pan-flavivirus vaccine. Your specific goal is to investigate presentation of viral antigens by dendritic cells and the cellular response to the vaccine.
Our research group focusses on dendritic cell biology and questions related to the differentiation and functional specialization of dendritic cell subpopulations in the context of inflammatory disease and viral infections. We are combining In vivo work in the murine immune system with in vitro studies using human immune cells from donors and patients (http://www.immunologie.med.uni-muenchen.de/research/ag_krug).
- Experience in cellular immunology and cell biology techniques
- Very good knowledge of immunology − Aptitude to teamwork, constructive discussion of results and creative thinking
- Excellent (oral and written) communication skills in English; basic German language skills are beneficial but not required
PhD students will benefit from a structured training platform provided by the Integrated Research Training Group 1054 ‘Cell-Fate Decisions in the Immune System’ (http://www.sfb1054.med.uni-muenchen.de), which is integrated into the Munich Medical Research School of the LMU (http://www.en.mmrs.med.uni-muenchen.de/index.html)
Applications should include letter of motivation, CV, references and certificates (all in one pdf file).
Please send your application to: firstname.lastname@example.org until 18.02.2018
Medical Doctor in Immunology
If you are interested in a doctoral position please send your application (including CV and references, motivation letter, certificates as one pdf file) to email@example.com at any time.
Currently no messages in this area.